EICHOR
● Active Not Recruiting
Phase 2 Study of EDG-5506 in Becker Muscular Dystrophy (GRAND CANYON)
Condition: Becker Muscular Dystrophy · Sponsor: Edgewise Therapeutics, Inc.
About this study
A study of sevasemten (EDG-5506) in Becker muscular dystrophy (known as CANYON) and pivotal cohort (known as GRAND CANYON). The EDG-5506-201 CANYON study was expanded to include an additional 120 adult participants in a cohort called GRAND CANYON, that is a multicenter, randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of sevasemten in adults with Becker. CANYON and GRAND CANYON are fully enrolled.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (51)
| Arkansas Children's Hospital | Little Rock, Arkansas, United States | — |
| UC San Diego | La Jolla, California, United States | — |
| UCLA Medical Center | Los Angeles, California, United States | — |
| UC Irvine Medical Center | Orange, California, United States | — |
| Stanford Neuroscience Health Center | Palo Alto, California, United States | — |
| UC Davis Medical Center | Sacramento, California, United States | — |
| UC Denver | Aurora, Colorado, United States | — |
| University of Florida | Gainesville, Florida, United States | — |
| Rare Disease Research | Atlanta, Georgia, United States | — |
| Northwestern University | Chicago, Illinois, United States | — |
| Indiana University School of Medicine | Indianapolis, Indiana, United States | — |
| University of Iowa | Iowa City, Iowa, United States | — |
+ 39 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.